WEBULL
WebtradeDownload

Ezaki Glico (TSE:2206) Half Year Earnings Put Its Valuation Back In Focus

Simply Wall St · 2d ago

Why Ezaki Glico’s latest half year earnings matter for shareholders

Ezaki Glico (TSE:2206) has just posted half year results to June 30, 2026, with sales of ¥180,369 million and net income of ¥4,973 million. Basic EPS from continuing operations reached ¥79.32.

This earnings update, released on August 5, 2026, gives investors fresh insight into how the confectionery and food producer is currently performing across its domestic and overseas segments, and how the stock might compare with recent share price moves.

See our latest analysis for Ezaki Glico.

Ezaki Glico’s latest earnings sit against a mixed share price picture, with the stock up 3.9% on the day to ¥5,079 but down 7.8% over 90 days, while the 3 year total shareholder return of 41.7% points to stronger longer term compounding.

If Ezaki Glico’s results have you rethinking where growth could come from next, it can be useful to scan related areas of the market through our AI infrastructure stock ideas in the 56 AI infrastructure stocks

Ezaki Glico trades at a sizeable discount to one estimate of fair value, yet above the average analyst target after the latest bounce. Is the market being overly cautious, or are risks still priced in for a reason?

Preferred P/E multiple of 49.7x, is it justified for Ezaki Glico?

On these latest numbers, Ezaki Glico looks expensive on a P/E basis, with the stock at ¥5,079 trading on 49.7x earnings compared with both peers and the broader JP Food industry.

The P/E ratio compares a company’s share price to its earnings per share. For a consumer staples business like Ezaki Glico, it effectively shows how much investors are currently willing to pay for each unit of profit, and often reflects expectations about future earnings strength and stability.

Here, the gap is clear. Ezaki Glico’s P/E of 49.7x stands well above the JP Food industry average of 15.5x and also sits ahead of the peer group average of 19.8x. It is also higher than the estimated Fair P/E Ratio of 28.8x that the SWS fair ratio model suggests the market could gravitate toward if pricing and fundamentals eventually align more closely.

Explore the SWS fair ratio for Ezaki Glico.

Result: Price-to-earnings of 49.7x (OVERVALUED)

However, Ezaki Glico’s premium P/E could be vulnerable if earnings momentum slows or if analysts remain cautious with a lower ¥3,900 price target.

Find out about the key risks to this Ezaki Glico narrative.

Another view on Ezaki Glico’s value

While the current P/E of 49.7x makes Ezaki Glico look expensive, the SWS DCF model presents a different perspective. It puts fair value at ¥9,199.47 per share, which is about 44.8% above the current ¥5,079 price and suggests the stock may be undervalued. Which signal matters more to you?

Look into how the SWS DCF model arrives at its fair value.

2206 Discounted Cash Flow as at Aug 2026
2206 Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ezaki Glico for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 18 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mix of positives and risks around Ezaki Glico feels finely balanced, take a moment now to review the data and shape your own view with the 2 key rewards and 3 important warning signs.

Looking for more Ezaki Glico investment ideas to compare?

If Ezaki Glico has sharpened your focus on quality and valuation, do not stop here. Broaden your watchlist now so you are not relying on a single story.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.